DEGREE: Medical Doctor MD. UNIVERSITY OF BUENOS AIRES. ARGENTINA.1987. GENERAL SURGEON DEGREE. Ministerio Salud Pública 1994. GYNECOLOGIST DEGREE. Min.Salud Pública 1997. MASTOLOGIST DEGREE. Min.Salud Pública 2001.
1- HEALTH SCIENCES PROFESSORSHIP: UNIVERSITY OF BUENOS AIRES (U.B.A.) 1991-1995. 2.- GENERAL SURGEON TEACHING PROFESSOR- AFFILIATED TO UNIVERSITY OF BUENOS AIRES. Since 1995 to present. 3.- MASTOLOGY ASSOCIATED TEACHER Sociedad Argentina de Mastologìa . Since 1997 to present. 4- MASTOLOGY COURSES Director/Coordinator: Total 23
1. RESIDENCY. GENERAL SURGERY. Hospital J.A.FERNANDEZ Buenos Aires.
2. RESIDENCY BREAST SURGERY PROGRAM. Hospital Piñero. Buenos
3. RESIDENCY CHIEF . General Surgery. Hospital J.A.FERNANDEZ BS.AS .
4. RESIDENCY INSTRUCTOR . General Surgery. H J.A.FERNANDEZ BS.AS .
5- EUROPEAN SCHOOL OF ONCOLOGY. "Medico frequentatore"Breast Surgery. Instituto Tumori de Milan. Chairman: Prof Dr. Umberto Veronesi. MILAN . ITALY. 1992. 6- UNIVERSITY SOUTHERN CALIFORNIA. Lee Breast Cancer Center “Breast Surgery Program”. Prof .Dr. Melvin Silverstein. Los Angeles California. USA. 2001 and 2006 7-SAO PAULO UNIVERSITY USP.Sao Paulo University “ONCOPLASTIC BREAST SURGERY”Prof. J.A. Pinotti. Sao Paulo. Brazil. 2004. CLINICAL PRACTICE 1- GYNECOLOGY. CLINICAL FACULTY. H.J.A.FERNANDEZ. 1994-1998. 2- MASTOLOGY CLINICAL FACULTY . H.J.A.FERNANDEZ-1994-1998 3- CHIEF OF BREAST IMAGE DEPARTAMENT. San Isidro Medicina. Since
4- CHIEF OF BREAST SURGERY DIVISION. Instituto Halitus. 1997-2006. 5- CHIEF OF BREAST INTERVENTIONISM DIVISION. DIAGNOMED. Ramos Mejia
6- DIRECTOR OF “BREAST CENTER INSTITUTE” ” Since 2004 to present. 7- FACULTY BREAST CANCER RESEARCH . IME Instituto Medico Especializado.
8- MASTOLOGY CLINICAL FACULTY . Hospital HIGA Eva Peròn (ex Castex). San
Martín. Pcia Bs. As. Since January 2007 to present.
AWARDS 1- “ESCUELA ARGENTINA DE MASTOLOGIA” AWARD: Best student and best monography "Breast feeding".1990. 2- "SOCIEDAD ARGENTINA DE MASTOLOGIA AWARD" 1991. "DIAGNOSIS OF NON PALPABLE BREAST CANCER" 3- " III INTERNATIONAL CONGRESS ON CANCEROLOGY " Breast High Risk Lesions " Best Selected oral presentation 1994. 4- "SCIENTIFIC AWARD HOSP.J.A.FERNANDEZ 1994" Local Recurrences after conservative treatment on early breast cancer" 5- FASGO GYNECOLOGY AWARD 1997 Federacion Argentina de Sociedades de Ginecologìa y Obstetricia . “Subclinical breast lesions ” . 6- SOGIBA AWARD 2000 Sociedad de Ginecologìa y Obstetricia de Buenos Aires. “CerbB2/Her2 Neu as a breast cancer prognostic factor ” Best Gynecology Poster 7- XI JORNADAS .ARGENTINAS MASTOLOGIA.2001.Best Poster ”Angiogenesis in breast cancer”” 8-“E.SCHIEPPATTI” ACCESIT AWARD 72ºArg. Cong. Surgery.2001 “CerbB2/Her2 neu as a prognostic factor on breast cancer”
1. GICMA Founder. Chairman. 2006 ( Argentinian Breast Cancer Research Group) 2. PACT Pan American Cancer Trials Network Collaborator. Baylor College of
3. IME de Buenos Aires. Breast Cancer Research Consultant. Advisory “Breast
MEMBERSHIP SCIENTIFIC COMMITTEES -ASOCIACION ARGENTINA DE CIRUGIA: since 1989. -SOCIEDAD ARGENTINA MASTOLOGIA:- since 1992 Board Member 1998-2000. 2004-2006 -SENOLOGIC INTERNATIONAL SOCIETY. Since 1996 -ASOC.ARGENTINA. CANCEROLOGIA. Since 2006 -ASOC. ARGENTINA DE ONCOLOGIA CLINICA: Since 2007
WRITTEN BOOK CHAPTERS: TOTAL: 13 (in colaboration) PEER-REVIEWED PAPERS: TOTAL:19 ABSTRACTS: TOTAL 67
1- NEOADYUVANT CHEMOTHERAPY ON STAGE III BREAST CANCER. II Iberoamerican Congress on Senology 1995 Selected Special Oral Session. 2.- DNA PLOIDY AND OTHER MOLECULAR PROGNOSTIC FACTORS CORRALTION ON BREAST CANCER. XII Latinamerican Congress on Mastology.II Simposyum Instituto Europeo Oncología. Selected to Premio U. Veronesi. Award 2003. 3.MULTICENTER STUDY VALIDATES PITX2 DNA METHYLATION FOR RISK PREDCITION IN TAMOXIFEN-TREATED , NODE NEGATIVE BREAST CANCER USING PARAFFIN-EMBEDDED TUMOR TISSUE. ASCO 2005 Annual meeting. Orlando USA. Selected to Oral Session Breast Track.
Source: http://www.breastcenter.com.ar/margossian%20astrid%20en.pdf
T r a v e l P o l i c y Approved Dec 20, 2007 IT IS THE INTENT OF THE RED RIVER NORDIC SKI CLUB TO OFFER HEALTHY AND SAFE TRAVEL-TO-EVENT OR TRAINING CAMP EXPERIENCES FOR OUR ATHLETES. TO FACILITATE THIS, THE FOLLOWING GUIDELINES HAVE BEEN DESIGNED TO OUTLINE EXPECTATIONS FOR MEDICATION AND ATHLETE AVAILABILITY ON TRIPS: THE ATHLETE'S PARENT OR GUARDIAN MUST PROPERLY FILL OUT A ME
BE–164 BODY ELECTRICAL REPLACEMENT 1. REPLACE TRANSMITTER (LITHIUM) BATTERY NOTICE: Special caution should be taken for handling each compo- nent as they are precision electronic components. (a) Using a screwdriver, remove the screw and cover. NOTICE: Do not pry out the cover forcibly. HINT:Push the cover with a finger as shown in the illustration, so thatthere becomes c